Conference Coverage
Conference Coverage
Myocardial infarction in women younger than 50: Lessons to learn
“Cardiovascular disease is the main cause of death in women, killing seven times more than breast cancer,” notes Dr. Manzo-Silberman.
Conference Coverage
Dietary change tops for reducing CVD risk in stage 1 hypertension
Healthy lifestyle changes, particularly adoption of the DASH diet, can reduce CVD events in people with stage 1 hypertension.
Conference Coverage
Hip fractures likely to double by 2050 as population ages
Greater efforts “are needed to prevent hip fractures and improve the treatment gap and post-fracture care, especially in men and the oldest old...
Latest News
Roflumilast foam effectively eases seborrheic dermatitis
The study evaluated a foam formulation of roflumilast, a PDE4 inhibitor that is available for topical use in a cream formulation that was recently...
Conference Coverage
Full-dose antithrombotic aids selected COVID-19 ICU patients
“We probably need to replace the guidelines.”
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...
Conference Coverage
RETHINC takes air out of COPD-like therapy for smokers
Bronchodilator therapy was no better than placebo at reducing respiratory symptoms in smokers without airway obstruction.
Conference Coverage
MR and PET perform similarly for assessing CAD
Head-to-head comparison of rubidium PET and cardiac MR showed comparable performance for identifying coronary obstructions.
Conference Coverage
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart disease
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS...
Conference Coverage
COVID-19 vaccine safe in patients with heart failure
There should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF; moreover, vaccines provide a survival benefit...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...